Related Experiment Video
Updated: Jan 29, 2026

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance
Published on: April 15, 2022
Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals
Saman Warnakulasuriya1, Kurt Straif2
1WHO Collaborating Centre for Oral Cancer, King's College London, London, UK.
Abstract:
A Working Group of the Monographs programme of the International Agency for Research on Cancer has classified smokeless tobacco as carcinogenic to humans (Group 1). This review article summarizes the data that support the evaluations of sufficient evidence in humans and in experimental animals for the carcinogenicity of smokeless tobacco whether used alone or with betel quid. It also identifies compounds of smokeless tobacco relevant to carcinogenicity (prominently tobacco-specific nitrosamines) and addiction (nicotine). The epidemiological evidence is summarized for oral cancer, other cancers associated with smokeless tobacco and oral potentially malignant lesions with a focus on analytical studies from the SEARO Region. Studies on cancer in experimental animals are summarized with a focus on studies applying smokeless tobacco products typical for the regions, such as mishri and naswar.
Related Concept Videos
The Evidence for Evolution
Mutagenicity and Carcinogenicity
Tonicity in Animals
Tonicity in Animals
Animal Mitochondrial Genetics
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

